0001193125-16-606563.txt : 20160629 0001193125-16-606563.hdr.sgml : 20160629 20160527170204 ACCESSION NUMBER: 0001193125-16-606563 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20160527 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Acadia Healthcare Company, Inc. CENTRAL INDEX KEY: 0001520697 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 6100 TOWER CIRCLE STREET 2: SUITE 1000 CITY: FRANKLIN STATE: TN ZIP: 37067 BUSINESS PHONE: 615-861-6000 MAIL ADDRESS: STREET 1: 6100 TOWER CIRCLE STREET 2: SUITE 1000 CITY: FRANKLIN STATE: TN ZIP: 37067 CORRESP 1 filename1.htm SEC Acceleration Request

LOGO

May 27, 2016

VIA EDGAR Submission

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Larry Spirgel, Assistant Director

 

  Re: Acadia Healthcare Company, Inc.
       Registration Statement on Form S-4
       File Number 333-211503

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, the undersigned, on behalf of Acadia Healthcare Company, Inc. (the “Company”), requests acceleration of the effective date of the above-captioned Registration Statement, as then amended, so that it will become effective at 11:00 a.m., Eastern time, on Wednesday, June 1, 2016, or as soon as practicable thereafter.

In connection with this request to accelerate the effective date of the Registration Statement, the Company acknowledges the following:

 

    should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

 

    the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

 

    the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.


If you have any questions or comments regarding this letter, please contact the undersigned at (615) 861-6000 or the Company’s legal counsel, James H. Nixon III of Waller Lansden Dortch & Davis, LLP at (615) 850-8855.

 

Very truly yours,
ACADIA HEALTHCARE COMPANY, INC.
By:  

/s/ Christopher L. Howard

  Name: Christopher L. Howard
 

Title:   Executive Vice President, General

            Counsel and Secretary

GRAPHIC 2 g191404g46h91.gif GRAPHIC begin 644 g191404g46h91.gif M1TE&.#=A^P!Q '< "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P M ^P!Q (?____W_^\Q.I0Q.H3W]_\Z0HR]Q>\9.I1:6HPI*8QC:ZV]O M[_]"4DJ4E,4Z&2D08Y00$)0Z6N\06N\Z6L406L5KA%HZ0AEC6LZ46N^46FN4 M6JUC6N\06FMK6BDZ&0B46LZ46DJ46HP06DIK6@@Z4FN^<[UI"[UI" MK5I"8QDQ*92<[QE"K1F<[YR_O&6OO&:WO&2GOC*WOC&OOC"G%4N_%4FO%4JW% M4BG%C._%&>_%&6O%&:W%&2G%C*W%C&O%C"GO4L[O4DJ<6@CO4HSO4@COC,[O M&<[O&4KO&8SO&0COC(SOC$KOC C%4L[%4DK%4HS%4@C%C,[%&<[%&4K%&8S% M&0C%C(S%C$K%C AS>ZWFYN_O[XSO[SK%[XS%[SKO[V/O[Q#%[V/%[Q 9*6OO MO6OOO:WOO2G%O6O%O2E"C.]"C*V4$*T0C.\0C*UC$*UKSFL0C&MKSBD0C"ES MA.\Z$)3%O8SOO4KOO8SOO0C%O4K%O0A"C,Y"C(R4$(P0C,X0C(QC$(QKSDH0 MC$IKS@@0C @Z,7.\0 M*>_%[\XZ*<40*<6^4I6M" MK:V4,:U"[ZV4*>]SI>\0*4I"[\Y"K9S>XP0*93_[_\(_P !"!Q(L*#!@P@3*ES(L*'#AQ C2IQ(L:+%BQ@S:MS( ML:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-FSASZMS)LZ?/GT"#"AU* MM*C1HTB3*EW*M*G3IU"C2IU*M:K5JUBS:MW*M:O7KV##BAU+MJS9LVC3JEW+ MMJW;MW#CRIU+MZ[=NWCSZMW+MZ_?OX"E!AC89>/@PP "'$9,L+##P0LA/TY, M67)#RP41,^;X+ROFB)\3=A8H^3"!B*,I)X3L.#3IRHDQNT:8>N!LA;>CILYM M<+/ UI7_01[<93A!UY*!$ZQML/!AY@]Y#^P,O7ABQY-A6SVM&N)@ZJ(_6O]? MS)![9O*6-;]>W[RR:>[0(0KO+I6[?8N(A<>W':!PX?T+S1<1 9"-9B X'$D MW64+)@49 0 B!"%I *9&P(7'V8;=08R9IQU"FJ&GG678=;8AAP X]]IIOEV& M('OU/4A,,A-)1@ F_!BC@!<%##/ *$,,$P!7BAPB3$&J'#:B0:-%D!G!"2S MP&X #G8:AOM=2."% 9S&W&P87BF0EA0]29)0Z9 $%[*E$GP+X,X 8Q) 9&P"/VIG CTH@$(:7UMKV(G>%/9L ,?TZ M99X8>!; YFZ_*G<)H @08:&K"!)S"0*A%!"-%Q@B"B6TFA* '9C6(6@ G@(D M(,8"!AA KPI%&,#/,<>@*P"T Q00RB4N.[8A >FBW"JPMWTW$-#4*C F5:<1 MD>D 2J"Y'HGT$J " ND.8$S!HAY-! *9*EUP=P2P("V>R!"(&B9G#Z K01Z> M9D Q/?)9 (WW#92MG@4P_\K;R (5\S2<3#[UI!CKAET0P-VI($8!Y6+BGK4, M"V2 %THH0+&_52.P)QG]+(=H0>P6P"ULOG4F.)_O8J(V:008DZFV'C9J$'=6 M$N" GC^^/=5@I.:I!)PBH]@FV GT/1]SKC*7S !B(UA)L7009L($N9U*:""3P50PQDP!,".G8H E#O9I>@36\$5" %YA!83:*7 M ?_NQ0($$$M3:GJ-9*B%I],=YW^<.TTZAG$V 2CM?RRP7F]T:!\##., + B: M%:MRC)O)['-$$-62$ 0V/,5I3LY!S(2".!!B% .!MEF&&U>G+61@CSF=P=./ M3F>T@T"';L0:DJZLQ _U=8R$(%H: !XF +03UIDD-Q2"ID8H"5 :02(UACI MI1D"\*-< M 'OVHDD&30:&R#:2$95+!?,S& MNP#J<"#(N-,Q"( ,$.9J5_3"WDX8AR B>&$8#@3 WF[FQP B3$\$^Q!JYK@0 M%F3*90KDT^L>,D$G0D1N8DS #P$01MYU3)H(&DP6_2'_.:#QKI*4<=)0S(,8 M+Y1K( M@%QF.$44O:DL E0/-=!X(.QB*82"RFQT_(.F0(YH.GRCB(YZX8S9B M%8!S[0,:] 92C'^N\#MXS E\K-1""M+K'WR[&>X&8LZ4792.'WE?*+9V&A7D M25,2:6<%HP. %O8)RJ1=#]=$D@"25#5$_CU+"9)Z8]F9,E;Z8"ZQ"@ MI9DJP *X-*8A[$E7N=2(^*YG)?'Q#IT/:1LO4=,E NPM4Z&C)_ST9$SC$0 ! M2G" ?0Z[)^(5#B@<;:I;9?6@(L0P99H#H#^;B%*)7$E,AE0!NGX(F05 S841 MX1-#+;* R]Y,(#T=*?Y*^(]F_PJ@&,;A!^_NIQJPZL0QLA/ "JO&HSUI4C@& M..I&EQH1Y?SJ()F#IHAA5A2NL1) MU 0=\$:C6(:Q /U? (S!)Q9()J&\6RYA@/@0GRE$6S^]:N!0IH1K0,26W(JL M0T;3QA"Z+(M/\Y"",W2GD[+/!B@+A0&Z]MO7E8@R"Y#6,O^!N_[[40*RAD+\V0QSP&* ?+)C2T2ZD A:P@!_$R.:+H'1/O75JK819C'4. M!$#(1%< U_5C%J%,5?IT 3S"&0Q]A7L0A^HIAR3LY4O,DYIL):";!LD6L1* M5PC_:?^XQU',.J,YIKYJ"1,MRS,+DE$,8OB8!<68E*0&K0!)<:I2A1:T OI! M:"/UV1@Y8D&>6^:ZJD532^J![>R&D<8I_XC,\X(18P> B>&(U7.8TB2=@U(R M%90KQ9(!#W[UI#3%A"MY G#B?;3$S)8MP!B KI3GJ)6 (.$,4S\ZF[0"E;*; MH2QKU4.VM(BEOJ>% D_W*E4"MKUM+W!*4C]F 3%:A@QE,?/'E^ 9/>\T@"%@ M^;F6(3$1]/0VAITUVMQZ;$TXW"L T V;^%O,A;)F1GHAX\?\V+"O_7R)1=3:986IF/$<(7O-JJ>$C##V>;$1N]5*4 E1(2$XUD9 M_.#S)1X'7CP=X++?/>K-ILHZ3*'K5/V@%+I,%W4@^YD8:#<&\FAM=K2+V^WB M_O%WB[3H4Q7ZV"+O.LGQ1(9UK0L!_2A&GRG-:Q8A UHIYK6_X/LCEXE9)I!) MQA"&<4>QBLP OV;!I1+PIZU?]ZFE*H"E)C5S8"=CW,H@=Q'B%)[1O&\80WL@ M$2RN "@FY&D%B!<>[8-G3-P<&0O0_ 0%K2XOY.Q'/@J%CR2%XV+@V0"NPR!H M6[G;S#X^)21.3E_S#'QC!!ILF%H5_[J^V^YV=8#@7DC=O^?NT8M 94Z93%V( RG!S0>9C@;9H2K NHH< @I<, M+5,81?4X@"(Y<343F* ,P?

#QA-0S]4/LZ,Y!$ ,C05J_6):8V0 M,;, R2!NEQ!X.$9Z-L SUX<2RH!G80"%$FB V7(W#2%:6 0M\\E)Y\A6F05(5?B.7Q# M,/PV$$KU>,#S76D# $AH3QP6:Z+8-R 5-.6R55*7_'@P61 $>4APV19?X&C+ERAX82:@\Q&@3P!95Q(=\$ M9Q+"B8U5::XQ.PD@9* Q&*9(!H;( F481+D#-H7X$)@P51Q4&?K6$F*"& Y5 M $SF* ! A"@#2CDXC_ X89%A-45G0?R0/ Z &]DW$*:(6K.A5*S_E#Y_0EKB M]50SQCG\<&TIYHB.4EW;A5(9R!*K$XTS&"S?98N'Y5H%,%T280!#X"_9,@ Y M%%.I,6OH@D=[D@ )QHP*]#3G0QD#2 :K%F?_8&:K55X(L65XX@5;-!,/0AC+ M)C6V\T2P@VIXLC5T$C37-95)F4_=J&+)=#.J9CP/0@ :-P!HLA]5M(.>Q4?A MY(R V"U 1"J*R2)J4ACVZ%*-81.+10"S)DD*,2NQHXDQ.1BZU5@(0)67<5BU M)A#'\'(_M3F@!1DV0(T#T)('D2X3%SIBM@!N)0 '9!RQ-0 [E1ZW>0 VF!X+ MD950IDK6&!.E,1C'^39%TYB)^2-#@$X!__"+")DK @5)\X%!<_(PJ]4EU;-, M")0<"!5M?>,MCO$/70!,II)/5K)SJ6,,P$@&UO<:=I4I2C)D)G21-P.80"B' M *!;=TAJJY:%'Q$F_X!?D$D:WN,O;DJ$,+&:+WU$:(X$7<]V[@BL<@WAMA4E&1+MR6>R\@L@_5^%,@N M0UE")W)65<1>BT,GMC25]_0E+\,"QIH). &,E03.4L=80T[@G M7L!Z-V678Q(E:?]5=/Z1$$QR,M:# <*HG:%AEZG HX=3A#+@IC-2UU,Q?% MB_?QBYI(J:>A#-$T@#I#*$1@;E5S(?^@ OQ /S$$/6*JH59#?[QS"0?J+9;T M-/G('E5R&N_#+I17:2"5$BUC-OKI=-<< IN52#-!G'BI01F+P-,Y6 M;:R# "Q#! I0/427<*HJDD>S .3Z73(D:0K'#\?)I[OE!9N2:,]B73=S#'"& MGP:W ##$.]=U#)3V#YCW+*?E!?RPA3\I(2P#-J@$7@B ))A0F"+Q#\H0=F+0 M#PVW:)? !?W@*Y>H#/I0:&%'*2?+:'CE&%\0?*@",FF%G I0#,:0-AG_FP.4 MDFX;BV,(M"$+H \78W?]P"D1[J*B'R4A!KF#^H MN1 ;F2B+:(#DUD^0*" DIC8)\J;CT21T&B"X(:7BH:[>C MR1".@4 1Y!4V8G2+.3J4BQ#8\5C*TAHU]+NS B7T APQ-B9W^U7GV!Y@18'% M:[?+RQ6/0@-A0"_ZT ]1FAF=<;W7NQYYDR*!_S4:JTL@_; /09BQ_4 #U[LO M^ -0%^S &S$ #YEM"^I ;!! &_> IT) EK>0I8_ 5CL$, MU4L ^[ "N<$%^J ,U?NH:9)>7; %^ZMO_[ "KT2Z^(,)81 "KP 8>"\S;$" MD1D&*[![8\ %7+4"^^$8R; %%-P> + % = //< 08= "!* /70$<'"P08< , M@VH0-!!8>GH0_= "*Y B-&00+2"0='L:*[# V<,=+5"] %#$Z740"R /]V5> M7; "+; /8+4% * ,:AQ)7?S$B$L4A^+$S, #\M "MD$Q^] "("MA4LS&:)** M E$#7/PK5R5A"MP;<_^V F:\ G>\$"K\$"(S!LD !@CD)5L P$!\B&"@#RO< M%0]RQ?02R0L1P %0O>^E&@NP!2L !MB[$"CLQK\BRG0KQ5Q,R@D1!C2\K#J\ M ID<&9D,!OOKH"H< %3,$5T NRSA(8G,P'B,&]V;KHO;!?U0O5^P!:K**YBA MP%U0;I=69P.1R&M)O (1RW3RS K1 RXL$)LL(3T0)Y[,$&I\S86,$ N Q\J@ MS!-!@?J\S%V\!5Q +XY5MBZB]E'RB-FZ03IBR8L7N=N]@-4=NW8]H<\E6CS7-&IQ5++;E=;=J[ M^]3C2-9]?1!XS23?R]C+:L(#F=NPPSFM#=T^P8N!*_'=X!W>XCW>Y%W>YGW> ?Z)W>ZKW>[-W>[OW>\!W?\CW?]%W?]GW?^,T6 0$ .P$! end